Role of Cardiac Rehabilitation in Blood Pressure and Glycaemic Control: An Integrated Approach to Cardiovascular Risk Management

Authors

  • Shivanjali Professor, Department of Physiotherapy, Dean Allied and Health Care Sciences, RasBihari Bose Subharti University Dehradun
  • Desh Deepak Ph.D. Physiology, RasBihari Bose Subharti University Dehradun
  • Anirban Patra Professor, Faculty of Allied health Care Science, Rasbihari Bose Subharti University Dehradun

DOI:

https://doi.org/10.69968/ijisem.2026v5i4324-330

Keywords:

Cardiac Rehabilitation, Hypertension, Diabetes Mellitus, Glycaemic Control, Cardiovascular Risk Management

Abstract

Cardiovascular diseases remain a leading cause of global morbidity and mortality, with hypertension and diabetes mellitus acting as major modifiable risk factors that frequently coexist. Cardiac rehabilitation (CR) is a multidisciplinary secondary prevention programme combining supervised exercise training, nutritional counselling, weight management, patient education, psychological support, and medication adherence. The role of CR in blood pressure regulation and glycemic control is discussed in this review, focusing on interventions based on exercise, lifestyle modification and integrated risk factor management. There is evidence to indicate that both aerobic and resistance training improve endothelial function, insulin sensitivity and metabolic health with subsequent reductions in blood pressure, fasting glucose and HbA1c. But the benefits to exercise capacity may be smaller and less sustained in patients with diabetes. Barriers including limited participation, cost, and poor adherence restrict long-term benefit. Individualised, comprehensive CR strategies, integrated with optimal pharmacological therapy, are essential to optimise long-term cardiovascular outcomes.

References

[1] M. L. Bluhm, K. N. Hoehing, R. K. Nelson, and M. N. Zuhl, “Effect of Type-2 Diabetes Mellitus on Cardiac Rehabilitation Outcomes: A Meta-analysis,” Arch. Phys. Med. Rehabil., vol. 103, no. 10, pp. 2016–2022, 2022, doi: https://doi.org/10.1016/j.apmr.2022.01.167.

[2] M. Kallistratos et al., “Exercise and cardiac rehabilitation in hypertensive patients with heart failure with preserved ejection fraction: A position statement on behalf of the Working Group of Arterial Hypertension of the Hellenic Society of Cardiology,” Hell. J. Cardiol., vol. 75, pp. 82–92, 2024, doi: 10.1016/j.hjc.2023.08.008.

[3] L. H. Yan, Y. Ge, F. Wang, Y. L. Zhu, and L. Lu, “The Impact of Continuous Cardiac Rehabilitation on the Psychological and Physiological Prognosis of Patients with Heart Failure—A Retrospective Study,” Ther. Clin. Risk Manag., vol. 21, pp. 1227–1236, 2025, doi: 10.2147/TCRM.S529282.

[4] M. D. Swarnkar, “Herbal Medicines in the Management of Diabetes: A Review of Plant-Based Remedies and Efficacy,” Int. J. Innov. Sci. Eng. Manag., vol. 4, no. 3, pp. 24–29, 2025, doi: 10.69968/ijisem.2025v4i324-29.

[5] M. Volpe, C. Calvieri, and A. Alonzo, “Modern cardiovascular risk management in clinical practice,” Hipertens. y Riesgo Vasc., vol. 26, no. 6, pp. 275–279, 2009, doi: https://doi.org/10.1016/j.hipert.2009.01.005.

[6] S. AlHarbi et al., “Cardiac Rehabilitation: A Literature Review of Benefits, Challenges, and Emerging Approaches,” Cureus, vol. 17, no. 10, 2025, doi: 10.7759/cureus.95648.

[7] A. Kleinrok, M. Krawczyk-Suszek, and B. Zams, “The Impact of Selected Risk Factors on the Frequency of Cardiac Rehabilitation: Part I,” J. Clin. Med., vol. 14, no. 8289, pp. 1–14, 2025, doi: 10.3390/jcm14238289.

[8] A. A. Damluji et al., “Benefits of Cardiac Rehabilitation: Mechanisms to Restore Function and Clinical Impact,” Circ. Res., vol. 137, pp. 255–272, 2025, doi: 10.1161/CIRCRESAHA.125.325705.

[9] M. Ambrosetti, “Cardiac rehabilitation and risk factor control: Always guaranteed results?,” Rev. Port. Cardiol., vol. 40, pp. 921–922, 2021.

[10] S. J. Cuccurullo, T. K. Fleming, H. Petrosyan, D. F. Hanley, and P. Raghavan, “Mechanisms and benefits of cardiac rehabilitation in individuals with stroke: emerging role of its impact on improving cardiovascular and neurovascular health,” Front. Cardiovasc. Med., vol. 11, pp. 1–9, 2024, doi: 10.3389/fcvm.2024.1376616.

[11] M. St. Clair, H. Mehta, M. Sacrinty, D. Johnson, and K. Robinson, “Effects of cardiac rehabilitation in diabetic patients: Both cardiac and noncardiac factors determine improvement in exercise capacity,” Clin. Cardiol., vol. 37, no. 4, pp. 233–238, 2014, doi: 10.1002/clc.22245.

[12] A. S. Babu and S. L. Grace, “Cardiac Rehabilitation for Hypertension Assessment and Control: Report From the International Council of Cardiovascular Prevention and Rehabilitation,” J. Clin. Hypertens., vol. 17, no. 11, pp. 831–836, 2015, doi: 10.1111/jch.12663.

[13] H. Bola, A. Rai, R. Penumaka, E. Ulucay, E. Levin, and D. Maron, “Cardiac Rehabilitation for Coronary Artery Disease: Gaps, Digital Models, and the Future of Personalized Prevention,” Am. J. Cardiol., vol. 262, pp. 16–27, 2026, doi: 10.1016/j.amjcard.2025.12.013.

[14] C. Kim and S. H. Lee, “The Effect of Home-Based Cardiac Rehabilitation on Cardiovascular Risk Factors Management,” Ann. Rehabil. Med., vol. 47, no. 4, pp. 272–281, 2023, doi: 10.5535/arm.23041.

[15] B. B. Gadager et al., “Are cardiac rehabilitation pathways influenced by diabetes: A cohort study,” Int. J. Cardiol., vol. 411, p. 132275, 2024, doi: 10.1016/j.ijcard.2024.132275.

[16] R. S. Taylor, H. M. Dalal, and S. T. J. McDonagh, “The role of cardiac rehabilitation in improving cardiovascular outcomes,” Nat. Rev. Cardiol., vol. 19, pp. 180–194, 2022, doi: 10.1038/s41569-021-00611-7.

[17] Z. Wu et al., “Long-term cardiovascular outcomes and risk factors in adult sepsis survivors: a systematic review and meta-analysis,” World J. Emerg. Med., vol. 16, no. 5, pp. 423–430, 2025, doi: 10.5847/wjem.j.1920-8642.2025.098.

[18] R. Hadidchi, P. Lee, S. Qiu, S. Changela, S. Henry, and T. Q. Duong, “Long-term outcomes of patients with pre-existing coronary artery disease after SARS-CoV-2 infection,” eBioMedicine, p. 8, 2025, doi: 10.1016/j.ebiom.2025.105778.

[19] B. B. Gadager, L. H. Tang, C. Sevel, P. Doherty, A. Harrison, and T. Maribo, “Change in exercise capacity after cardiac rehabilitation following coronary heart disease in patients with and without diabetes: A follow-up study,” Int. J. Cardiol., vol. 444, p. 134005, 2026, doi: 10.1016/j.ijcard.2025.134005.

[20] M. Zhang et al., “Effects of exercise-based cardiac rehabilitation for coronary heart disease combined with diabetes mellitus: a systematic review and meta-analysis,” BMC Cardiovasc. Disord., vol. 26, no. 305, 2026, doi: 10.1186/s12872-026-05606-1.

[21] K. Peter, O. Roka, E. Sepp, M. Warburton, J. Zhang, and S. C. Cork, “The long-term cardiovascular safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in high-risk cardiovascular populations: a systematic review and meta-analysis,” Cardiovasc. Diabetol. – Endocrinol. Reports, vol. 12, no. 36, pp. 36-, 2026, [Online]. Available: https://link.springer.com/article/10.1186/s40842-026-00295-3

[22] C. A. Adam et al., “Cardiac Rehabilitation and Cardiovascular Prevention in Patients with Type 2 Diabetes Mellitus: From Initial Assessment to Comprehensive Management,” J. Clin. Med., vol. 14, no. 21, pp. 1–21, 2025, doi: 10.3390/jcm14217791.

[23] E. Paz et al., “Comprehensive Cardiovascular Risk Factor Control With a Mobile Health Cardiovascular Risk Self-Management Program,” J. Am. Heart Assoc., vol. 13, no. e033328, pp. 1–13, 2024, doi: 10.1161/JAHA.123.033328.

[24] E. Senesael, S. Pardaens, S. Cuypers, and S. Brouwers, “Influence of cardiac rehabilitation on blood pressure in patients with coronary artery disease,” Eur. J. Prev. Cardiol., vol. 30, p. 11212, 2023, doi: 10.1093/eurjpc/zwad125.123.

[25] P. Eser et al., “Clinical outcomes after cardiac rehabilitation in elderly patients with and without diabetes mellitus: The EU-CaRE multicenter cohort study,” Cardiovasc. Diabetol., vol. 19, no. 37, pp. 1–12, 2020, doi: 10.1186/s12933-020-01013-8.

Downloads

Published

17-11-2026

Issue

Section

Articles

How to Cite

Shivanjali, Desh Deepak, & Anirban Patra. (2026). Role of Cardiac Rehabilitation in Blood Pressure and Glycaemic Control: An Integrated Approach to Cardiovascular Risk Management. International Journal of Innovations in Science Engineering And Management, 5(4), 324-330. https://doi.org/10.69968/ijisem.2026v5i4324-330